Pharmaids Pharmaceuticals Ltd — Updates, 04-07-2025: Company Update

Pharmaids Pharmaceuticals Limited has announced a board meeting on July 4, 2025, where it approved the re-appointment of Mr. T. N Raghavendra as Internal Auditor for FY 2025-26. The company also approved the divestment of its entire 66.50% partnership stake in Anugraha Chemicals to Mr. Sourabh Hadimani or his nominee, aiming to focus on new ventures and strengthen ongoing businesses. Shareholders’ approval for this sale and related party transactions with Koye Lifesciences will be sought through a postal ballot. The sale consideration for Anugraha Chemicals is Rs. 10.50 Cr.